These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 2946712

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Maturation of the normal pituitary-testicular axis, as assessed by gonadotropin-releasing hormone agonist challenge.
    Ghai K, Rosenfield RL.
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1336-40. PubMed ID: 8200935
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE, Macchi M, Montanini V, Mongioi A, Maugeri G, Vicari E, Coniglione F, Sipione C, D'Agata R.
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [Abstract] [Full Text] [Related]

  • 5. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
    Garibaldi LR, Aceto T, Weber C, Pang S.
    J Clin Endocrinol Metab; 1993 Apr; 76(4):851-6. PubMed ID: 8473395
    [Abstract] [Full Text] [Related]

  • 6. A new test of combined pituitary-testicular function using the gonadotropin-releasing hormone agonist nafarelin in the differentiation of gonadotropin deficiency from delayed puberty: pilot studies.
    Ehrmann DA, Rosenfield RL, Cuttler L, Burstein S, Cara JF, Levitsky LL.
    J Clin Endocrinol Metab; 1989 Nov; 69(5):963-7. PubMed ID: 2529266
    [Abstract] [Full Text] [Related]

  • 7. Acute hormonal responses to the gonadotropin releasing hormone agonist leuprolide: dose-response studies and comparison to nafarelin--a clinical research center study.
    Rosenfield RL, Perovic N, Ehrmann DA, Barnes RB.
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3408-11. PubMed ID: 8784105
    [Abstract] [Full Text] [Related]

  • 8. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D, Steingold K, Cedars M, Lu JK, Meldrum DR, Judd HL, Chang RJ.
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [Abstract] [Full Text] [Related]

  • 9. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M, Campaniello E, Michelacci L, Pareschi A, Ferrari P, Bolelli G, Flamigni C.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [Abstract] [Full Text] [Related]

  • 10. Maturation of gonadotropin and sex steroid responses to gonadotropin-releasing hormone agonist in males.
    Cuttler L, Rosenfield RL, Ehrmann DA, Kreiter M, Burstein S, Cara JF, Levitsky LL.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):362-6. PubMed ID: 8432780
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Loumaye E, Fauser BC.
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [Abstract] [Full Text] [Related]

  • 14. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
    Ibañez L, Hall JE, Potau N, Carrascosa A, Prat N, Taylor AE.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
    [Abstract] [Full Text] [Related]

  • 15. Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins.
    Apter D, Bützow TL, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1993 Apr; 76(4):940-9. PubMed ID: 8473410
    [Abstract] [Full Text] [Related]

  • 16. Central precocious puberty: a single blood sample after gonadotropin-releasing hormone agonist administration in monitoring treatment.
    Salerno M, Di Maio S, Gasparini N, Mariano A, Macchia V, Tenore A.
    Horm Res; 1998 Apr; 50(4):205-11. PubMed ID: 9838241
    [Abstract] [Full Text] [Related]

  • 17. Treatment of hirsutism with a gonadotropin-releasing hormone agonist (nafarelin).
    Andreyko JL, Monroe SE, Jaffe RB.
    J Clin Endocrinol Metab; 1986 Oct; 63(4):854-9. PubMed ID: 2943756
    [Abstract] [Full Text] [Related]

  • 18. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.
    Christman GM, Randolph JF, Kelch RP, Marshall JC.
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845
    [Abstract] [Full Text] [Related]

  • 19. Maturation of the hypothalamo-pituitary-ovarian axis in adolescent girls.
    Lemarchand-Béraud T, Zufferey MM, Reymond M, Rey I.
    J Clin Endocrinol Metab; 1982 Feb; 54(2):241-6. PubMed ID: 6798063
    [Abstract] [Full Text] [Related]

  • 20. Gonadotropin-releasing hormone agonist analog (nafarelin): a useful diagnostic agent for the distinction of constitutional growth delay from hypogonadotropic hypogonadism.
    Kletter GB, Rolfes-Curl A, Goodpasture JC, Solish SB, Scott L, Henzl MR, Beitins IZ.
    J Pediatr Endocrinol Metab; 1996 Feb; 9(1):9-19. PubMed ID: 8887129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.